These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 28855393)
1. FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle. Sarkar S; Ryan EL; Royle SJ Open Biol; 2017 Aug; 7(8):. PubMed ID: 28855393 [TBL] [Abstract][Full Text] [Related]
2. Transforming fusions of FGFR and TACC genes in human glioblastoma. Singh D; Chan JM; Zoppoli P; Niola F; Sullivan R; Castano A; Liu EM; Reichel J; Porrati P; Pellegatta S; Qiu K; Gao Z; Ceccarelli M; Riccardi R; Brat DJ; Guha A; Aldape K; Golfinos JG; Zagzag D; Mikkelsen T; Finocchiaro G; Lasorella A; Rabadan R; Iavarone A Science; 2012 Sep; 337(6099):1231-5. PubMed ID: 22837387 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation. Nelson KN; Meyer AN; Siari A; Campos AR; Motamedchaboki K; Donoghue DJ Mol Cancer Res; 2016 May; 14(5):458-69. PubMed ID: 26869289 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic FGFR3 gene fusions in bladder cancer. Williams SV; Hurst CD; Knowles MA Hum Mol Genet; 2013 Feb; 22(4):795-803. PubMed ID: 23175443 [TBL] [Abstract][Full Text] [Related]
5. A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Akbulut O; Lengerli D; Saatci O; Duman E; Seker UOS; Isik A; Akyol A; Caliskan B; Banoglu E; Sahin O Mol Cancer Ther; 2020 Jun; 19(6):1243-1254. PubMed ID: 32217742 [TBL] [Abstract][Full Text] [Related]
6. Aurora-A-Dependent Control of TACC3 Influences the Rate of Mitotic Spindle Assembly. Burgess SG; Peset I; Joseph N; Cavazza T; Vernos I; Pfuhl M; Gergely F; Bayliss R PLoS Genet; 2015 Jul; 11(7):e1005345. PubMed ID: 26134678 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability. Wang CG; Peiris MN; Meyer AN; Nelson KN; Donoghue DJ Oncotarget; 2023 Feb; 14():133-145. PubMed ID: 36780330 [TBL] [Abstract][Full Text] [Related]
8. Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma. Yuan L; Liu ZH; Lin ZR; Xu LH; Zhong Q; Zeng MS Cancer Biol Ther; 2014; 15(12):1613-21. PubMed ID: 25535896 [TBL] [Abstract][Full Text] [Related]
9. The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival. Schneider L; Essmann F; Kletke A; Rio P; Hanenberg H; Wetzel W; Schulze-Osthoff K; Nürnberg B; Piekorz RP J Biol Chem; 2007 Oct; 282(40):29273-83. PubMed ID: 17675670 [TBL] [Abstract][Full Text] [Related]
10. FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling. Daly C; Castanaro C; Zhang W; Zhang Q; Wei Y; Ni M; Young TM; Zhang L; Burova E; Thurston G Oncogene; 2017 Jan; 36(4):471-481. PubMed ID: 27345413 [TBL] [Abstract][Full Text] [Related]
11. Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma. Di Stefano AL; Fucci A; Frattini V; Labussiere M; Mokhtari K; Zoppoli P; Marie Y; Bruno A; Boisselier B; Giry M; Savatovsky J; Touat M; Belaid H; Kamoun A; Idbaih A; Houillier C; Luo FR; Soria JC; Tabernero J; Eoli M; Paterra R; Yip S; Petrecca K; Chan JA; Finocchiaro G; Lasorella A; Sanson M; Iavarone A Clin Cancer Res; 2015 Jul; 21(14):3307-17. PubMed ID: 25609060 [TBL] [Abstract][Full Text] [Related]
12. Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration. Banella C; Ginevrino M; Catalano G; Fabiani E; Falconi G; Divona M; Curzi P; Panetta P; Voso MT; Noguera NI Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):163-168. PubMed ID: 32199932 [TBL] [Abstract][Full Text] [Related]
13. Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples. Kurobe M; Kojima T; Nishimura K; Kandori S; Kawahara T; Yoshino T; Ueno S; Iizumi Y; Mitsuzuka K; Arai Y; Tsuruta H; Habuchi T; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Kakehi Y; Nagumo Y; Tsutsumi M; Oikawa T; Kikuchi K; Nishiyama H PLoS One; 2016; 11(12):e0165109. PubMed ID: 27930669 [TBL] [Abstract][Full Text] [Related]
14. FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma. Gött H; Uhl E Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955806 [TBL] [Abstract][Full Text] [Related]
15. Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients. Ou SI; Horn L; Cruz M; Vafai D; Lovly CM; Spradlin A; Williamson MJ; Dagogo-Jack I; Johnson A; Miller VA; Gadgeel S; Ali SM; Schrock AB Lung Cancer; 2017 Sep; 111():61-64. PubMed ID: 28838400 [TBL] [Abstract][Full Text] [Related]
16. Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Ulisse S; Baldini E; Toller M; Delcros JG; Guého A; Curcio F; De Antoni E; Giacomelli L; Ambesi-Impiombato FS; Bocchini S; D'Armiento M; Arlot-Bonnemains Y Endocr Relat Cancer; 2007 Sep; 14(3):827-37. PubMed ID: 17914111 [TBL] [Abstract][Full Text] [Related]
17. FGFR3 signaling and function in triple negative breast cancer. Chew NJ; Nguyen EV; Su SP; Novy K; Chan HC; Nguyen LK; Luu J; Simpson KJ; Lee RS; Daly RJ Cell Commun Signal; 2020 Jan; 18(1):13. PubMed ID: 31987043 [TBL] [Abstract][Full Text] [Related]
18. Clathrin recruits phosphorylated TACC3 to spindle poles for bipolar spindle assembly and chromosome alignment. Fu W; Tao W; Zheng P; Fu J; Bian M; Jiang Q; Clarke PR; Zhang C J Cell Sci; 2010 Nov; 123(Pt 21):3645-51. PubMed ID: 20923838 [TBL] [Abstract][Full Text] [Related]
19. Clathrin heavy chain mediates TACC3 targeting to mitotic spindles to ensure spindle stability. Lin CH; Hu CK; Shih HM J Cell Biol; 2010 Jun; 189(7):1097-105. PubMed ID: 20566684 [TBL] [Abstract][Full Text] [Related]
20. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. Parker BC; Annala MJ; Cogdell DE; Granberg KJ; Sun Y; Ji P; Li X; Gumin J; Zheng H; Hu L; Yli-Harja O; Haapasalo H; Visakorpi T; Liu X; Liu CG; Sawaya R; Fuller GN; Chen K; Lang FF; Nykter M; Zhang W J Clin Invest; 2013 Feb; 123(2):855-65. PubMed ID: 23298836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]